Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial.

Tissue antigens - 1 Feb 2015

Baldwin K M, Ehrenberg P K, Geretz A, Prentice H A, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, O'Connell R J, Kim J H, Thomas R

Abstract excerpt

The RV144 HIV vaccine trial in Thailand elicited antibody responses to the envelope of HIV-1, which correlated significantly with the risk of HIV-1 acquisition. Human leukocyte antigen (HLA) class II molecules are essential in antigen presentation to CD4 T cells for activation of B cells to produ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Histocompatibility Antigens Class II
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-DP beta-Chains

Share to HLA-DQ beta-Chains

Share to HLA-DRB1 Chains

Share to Placebos

Share to Thailand

Source

Open in PubMed Open full text

Identifiers

PMID: 25626602
DOI: 10.1111/tan.12507
PMCID: PMC4552183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25626602-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial.PMID 25626602Read ↗

HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.Semantic proximity Read ↗

Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.Semantic proximity Read ↗

FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells.Semantic proximity Read ↗

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.Semantic proximity Read ↗

Phylodynamics of HIV-1 from a phase III AIDS vaccine trial in Bangkok, Thailand.Semantic proximity Read ↗

HLA Class II Genes HLA-DRB1, HLA-DPB1, and HLA-DQB1 Are Associated With the Antibody Response to Inactivated Japanese Encephalitis VaccineSemantic proximity Read ↗

The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.Semantic proximity Read ↗

HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition.Semantic proximity Read ↗

A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.Semantic proximity Read ↗

Nucleotide sequence polymorphism at the apical membrane antigen-1 locus reveals population history of Plasmodium vivax in Thailand.Semantic proximity Read ↗

HLA-associated immune pressure on Gag protein in CRF01_AE-infected individuals and its association with plasma viral load.Semantic proximity Read ↗

Designing peptide-based HIV vaccine for Chinese.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.